In a secondary analysis of 1160 patients with breast cancer in the RadComp trial, proton RT gave lower mean whole-heart dose than photon RT (0.89 vs 2.99 Gy), but no cardiac dose-volume metric was associated with cardiac-related quality of life over 6 months.
Secondary analysisn = 1,160
Wright et al. Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial